SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
NCT ID: NCT04972721
Last Updated: 2025-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3400 participants
OBSERVATIONAL
2023-09-01
2033-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
SELECT-LIFE study is a survey-based study that will start when the SELECT trial ends.
SELECT-LIFE looks at the long-term effects of participants taking part in the SELECT trial including the trial medicine participants have been taking.
When the SELECT trial ends, participants will no longer get the medicine participants got in the study, even if participants decide to take part in the SELECT-LIFE study.
Participants will not get any specific treatment or medicine as part of the SELECT-LIFE study, and participants will be treated as participants normally would by their own doctor.
The SELECT-LIFE study will last for up to 10 years after SELECT trial ends, and participants will be asked to fill in a questionnaire about their health every 6 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
NCT03574597
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
NCT04251156
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
NCT05564117
Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
NCT04074161
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
NCT05040971
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Questionnaire survey
Participants of the SELECT trial (EX9536-4388 ) are invited to transition to SELECT-LIFE (follow-up study) when SELECT ends.
No treatment given
The study is non-interventional with no study-specific treatment during the study and the patients will be treated as per Treating Physician's and patient's own discretion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No treatment given
The study is non-interventional with no study-specific treatment during the study and the patients will be treated as per Treating Physician's and patient's own discretion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed SELECT-LIFE consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
Exclusion Criteria
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novo Nordisk A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Transparency (dept. 2834)
Role: STUDY_DIRECTOR
Novo Nordisk A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Master Centre for USA
Plainsboro, New Jersey, United States
Master Centre for Algeria
Algiers, , Algeria
Master Centre for Argentina
Prov. de Buenos Aires, , Argentina
Master Centre for Australia
North Sydney, New South Wales, Australia
Cárdio Pulmonar da Bahia
Salvador, Estado de Bahia, Brazil
Hospital do Coração do Brasil
Brasília, Federal District, Brazil
Eurolatino Medical Research Center
Uberlândia, Minas Gerais, Brazil
Núcleo de Pesquisa Clínica S/S
Curitiba, Paraná, Brazil
Hospital São Vicente de Paulo
Passo Fundo, Rio Grande do Sul, Brazil
AngioCor Blumenau
Blumenau, Santa Catarina, Brazil
Instituto de Pesquisa Clínica de Campinas
Campinas, São Paulo, Brazil
CIP Centro Integrado de Pesquisas do Hospital de Base
São José do Rio Preto, São Paulo, Brazil
CPQuali Pesquisa Clínica Ltda
São Paulo, São Paulo, Brazil
CPCLIN - Centro de Pesquisas Clínicas
São Paulo, São Paulo, Brazil
Instituto Dante Pazzanese de Cardiologia
São Paulo, São Paulo, Brazil
Departamento de Gastroenterologia - HCFMUSP
São Paulo, São Paulo, Brazil
Instituto do Coração - HCFMUSP
São Paulo, São Paulo, Brazil
Master Centre for Brazil
Säo Paulo, São Paulo, Brazil
Instituto Brasil de Pesquisa Clinica
Rio de Janeiro, , Brazil
Master Centre for Canada
Mississauga, Ontario, Canada
Novo Nordisk Croatia Ltd.
Zagreb, , Croatia
Master Centre for Denmark
Copenhagen S, , Denmark
Master Centre for Finland
Espoo, , Finland
Master Centre for Germany PMS
Mainz, , Germany
Master Centre for Greece
Vouliagment, , Greece
Master centre for India
Bangalore, , India
Master Centre for Ireland
Dublin, , Ireland
Master Centre for Italy
Rome, , Italy
Master Centre for Japan
Tokyo, , Japan
MAster Centre for Latvia
Marupes, , Latvia
Master Centre for Malaysia
Selangor Darul Ehsan, , Malaysia
Master Centre Netherlands
Alphen aan den Rijn, , Netherlands
Master Centre for Norway
Rud, , Norway
Master Centre for South Africa
Sandton, Gauteng, South Africa
Master Centre for Sweden
Malmo, , Sweden
Master Centre for Tawain
Taipei, , Taiwan
Master Centre for Thailand
Bangkok, , Thailand
Master Centre for United Kingdom
Gatwick, West Sussex, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1255-5644
Identifier Type: OTHER
Identifier Source: secondary_id
EX9536-4750
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.